Non-COVID research statement
The Oxford Vaccine Group will be continuing with some of our non-COVID research, particularly our paediatric studies, during the COVID-19 pandemic. This is because as part of these studies we give babies their routine primary immunisations on behalf of their GPs. This reduces the administrative burden on the NHS, allowing them to free up capacity and prioritise their workload to be focused on doing what is necessary to manage the response to the COVID-19 pandemic. The participants also benefit from having the vaccines in the safety of their homes or a convenient location.
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Davis K. et al, (2021), Lancet Infect Dis
Publisher Correction: A guide to vaccinology: from basic principles to new developments
Pollard AJ. and Bijker EM., (2021), Nature Reviews Immunology
SIMON: Open-Source Knowledge Discovery Platform
Tomic A. et al, (2021), Patterns, 2, 100178 - 100178
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
A guide to vaccinology: from basic principles to new developments.
Pollard AJ. and Bijker EM., (2020), Nat Rev Immunol